MX9205722A - Composicion alimenticia enteral contra el cancer - Google Patents

Composicion alimenticia enteral contra el cancer

Info

Publication number
MX9205722A
MX9205722A MX9205722A MX9205722A MX9205722A MX 9205722 A MX9205722 A MX 9205722A MX 9205722 A MX9205722 A MX 9205722A MX 9205722 A MX9205722 A MX 9205722A MX 9205722 A MX9205722 A MX 9205722A
Authority
MX
Mexico
Prior art keywords
food composition
against cancer
composition against
enteral
cancer
Prior art date
Application number
MX9205722A
Other languages
English (en)
Inventor
Shozo Aoi
Goro Ebisu
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MX9205722A publication Critical patent/MX9205722A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invención provee una composición alimenticia caracterizada porque contiene la variedad descrita aminoácidos, grasa y carbohidrato. Esta composición alimenticia enteral contra el cáncer puede ser administrada por la vía oral o a través de un tubo para lograr la alimentación de los pacientes de cáncer y la inhibición del crecimiento de las células del tumor en los pacientes. Además, usada en combinación con un agente quimoterapéutico contra el cáncer, aumenta sinergísticamente la eficacia contra el tumor del último agente.
MX9205722A 1991-10-07 1992-10-06 Composicion alimenticia enteral contra el cancer MX9205722A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25888391 1991-10-07

Publications (1)

Publication Number Publication Date
MX9205722A true MX9205722A (es) 1993-11-01

Family

ID=17326356

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205722A MX9205722A (es) 1991-10-07 1992-10-06 Composicion alimenticia enteral contra el cancer

Country Status (9)

Country Link
EP (1) EP0560989B1 (es)
KR (1) KR0172193B1 (es)
AT (1) ATE183923T1 (es)
AU (1) AU651738B2 (es)
CA (1) CA2097196C (es)
DE (1) DE69229910T2 (es)
MX (1) MX9205722A (es)
TW (1) TW394686B (es)
WO (1) WO1993006834A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
MX9707584A (es) * 1995-04-07 1998-02-28 Abbott Lab Complementos de calcio y bebidas que contienen calcio y que comprenden vitamina d.
WO1998004255A1 (en) * 1996-07-30 1998-02-05 Novartis Nutrition Ag Amino acid composition and use thereof in treating tumor growth and metastasis
EP0875155A1 (en) * 1997-05-01 1998-11-04 N.V. Nutricia Peri-operative drink
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
WO2000068251A1 (en) 1999-05-07 2000-11-16 The University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
JP2003521481A (ja) * 1999-10-22 2003-07-15 プロビオティックス・インコーポレイテッド 新生児壊死性腸炎及び他の消化管粘膜損傷の予防における経口グルタミン
WO2002069964A1 (en) * 2001-03-05 2002-09-12 Ernest Stephen P Enteral formulation
WO2003030890A1 (fr) * 2001-10-05 2003-04-17 Tetsuro Asao Activateurs du systeme immunitaire
JP4147280B2 (ja) * 2003-12-16 2008-09-10 独立行政法人理化学研究所 グルタミン含有エネルギー付加型アミノ酸組成物又はアミノ酸溶液
JP4815752B2 (ja) 2004-04-01 2011-11-16 味の素株式会社 アミノ酸含有飲食品
FR2872704B1 (fr) * 2004-07-12 2007-11-02 Laurent Schwartz Pluritherapie contre le cancer
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
WO2008119077A1 (en) 2007-03-28 2008-10-02 University Of Southern California Induction of differential stress resistance and uses thereof
CA3045883C (en) * 2008-04-24 2022-06-28 University Of Southern California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
WO2014197533A2 (en) 2013-06-05 2014-12-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Palatable foods for a methionine-restricted diet
US12109191B2 (en) * 2017-10-02 2024-10-08 Amilyfe, Llc Materials and methods for inhibiting tumor growth
KR102262008B1 (ko) * 2018-06-28 2021-06-09 연세대학교 산학협력단 수크로오스를 유효성분으로 포함하는 항암용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025650A (en) * 1975-11-24 1977-05-24 Control Drug, Inc. Method and composition for preventing nutritional deficiency
JPS5535049A (en) * 1978-09-04 1980-03-11 Otsuka Pharmaceut Factory Inc Amino acid transfusion for cancerous patient
JPS56110617A (en) * 1980-02-08 1981-09-01 Ajinomoto Co Inc Nutrient composition for young child
JPS59193814A (ja) * 1983-04-20 1984-11-02 Ajinomoto Co Inc アミノ酸含有脂肪乳剤
FR2591893B1 (fr) * 1985-12-19 1988-11-10 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
JPH02134326A (ja) * 1988-11-14 1990-05-23 Snow Brand Milk Prod Co Ltd 高度侵襲用経腸栄養剤
JP2537406B2 (ja) * 1989-05-19 1996-09-25 株式会社大塚製薬工場 癌用アミノ酸製剤
DE3916903A1 (de) * 1989-05-24 1991-02-28 Leopold Pharma Gmbh Waessrige zusammensetzung fuer die parenterale ernaehrung
JP2744648B2 (ja) * 1989-06-29 1998-04-28 協和醗酵工業株式会社 アミノ酸顆粒の製造法
JPH0368514A (ja) * 1989-08-09 1991-03-25 Morishita Pharmaceut Co Ltd 癌用アミノ酸製剤

Also Published As

Publication number Publication date
ATE183923T1 (de) 1999-09-15
DE69229910D1 (de) 1999-10-07
KR0172193B1 (ko) 1999-02-01
EP0560989A1 (en) 1993-09-22
EP0560989A4 (es) 1994-02-02
KR930702969A (ko) 1993-11-29
DE69229910T2 (de) 2000-04-20
AU2691392A (en) 1993-05-03
EP0560989B1 (en) 1999-09-01
TW394686B (en) 2000-06-21
CA2097196A1 (en) 1993-04-08
CA2097196C (en) 1999-04-13
AU651738B2 (en) 1994-07-28
WO1993006834A1 (fr) 1993-04-15

Similar Documents

Publication Publication Date Title
MX9205722A (es) Composicion alimenticia enteral contra el cancer
Savarese et al. Prevention of chemotherapy and radiation toxicity with glutamine
US5053429A (en) Treating inflammatory pain with methionine
HUP0301386A2 (hu) Enterálisan beadandó kiegészítż táplálék kritikus állapotban lévż betegek, krónikus betegségekben szenvedż vagy alultáplált személyek parenterális táplálására vagy részleges enterális/orális táplálására
AU762481C (en) Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders
KR920000324A (ko) 필수 지방산 처리법
FI940787A (fi) Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
NO20023684D0 (no) Pediatrisk formulering
GB2596849A (en) Nutritional supplement composition for treating coronavirus infections, cancer, ME, post viral & Chronic fatigue syndrome & neurodegeneration in an individual
YU48583B (sh) Postupak za pripremanje formulacije u obliku pilule za oralno davanje
EP0396616A4 (en) Reduction of side effects of cancer therapy
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
US20210154241A1 (en) Compositions and methods for enhancing hyperthermia therapy
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
MXPA05003732A (es) Metodos y composiciones para proporcionar glutamina.
DE60008276D1 (de) Magensaftresistente tablette für nahrung, diät und therapie
HK1068824A1 (en) Insulin for use in a dosage regime
US6468988B1 (en) Composition that regulates and diminishes appetite and methods relating thereto
Ali Use of acacia gum in the treatment of skin lesions of two children with Kwashiorkor
EP1033133A4 (en) COMPOSITION FOR TREATING DIABETES AND METHOD FOR TREATING DIABETES
IE853206L (en) Use of aminosulfonic acids in treatment of inflammatory¹conditions
GB2182558A (en) Oral fructo-oligosaccharide pharmaceutical compositions
Cheraskin The diet dilemma in dentistry
Vazquez Comparing oxandrin and anadrol-50
Wu et al. Cytotoxic activity of FK973 against human oral and breast cancer cells